A new immunization for respiratory syncytial virus (RSV) is proving highly effective in preventing severe cases in infants. Vermont and New York have some of the highest RSV immunization rates ...

Britain's health regulator said on Friday it has approved Moderna's vaccine for respiratory syncytial virus in adults 60 ...

Robust immune responses were observed among healthy and high-risk younger adults who received the Ad26/protein RSV preF vaccine.

A study found that around 4 months after vaccination, people who received the RSV vaccine had a 79% reduction in their risk ...

The respiratory syncytial virus (RSV) vaccine triggered strong immune responses among people aged 60 years and older during ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

The shot, also known as the mRESVIA is used for preventing the lower respiratory tract disease in older adults. As per the ...

Prior to vaccine availability, RSV was a significant cause of illness and hospitalization in older adults in the U.S., ...

Feb. 19, 2025 – A vaccine for pregnant women that protects babies from respiratory syncytial virus (RSV) appears safe, according to two new studies that give researchers hope for widespread ...

What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...

Expectant mums and elderly people who haven’t yet had their vaccination against the life-threatening RSV virus that is spreading in London ...

Local health boards invited adults aged 75–79, including those turning 75 before July 2025, to come forward for their free ...